After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Esperion Therapeutics Inc. is $319.55M. A total of 5.37 million shares were traded on the day, compared to an average of 4.99M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, ESPR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 16 SELLs from insiders. Insiders purchased 286,561 shares during that period but sold 37,542.
In the most recent transaction, Warren Eric sold 742 shares of ESPR for 1.25 per share on Sep 20. After the transaction, the Chief Commercial Officer now owns 68,318 company shares. In a previous transaction on Aug 18, Warren Eric sold 243 shares at 1.41 per share. ESPR shares that Chief Commercial Officer owns now total 69,060.
Among the insiders who sold shares, Warren Eric disposed of 106 shares on Jul 19 at a per-share price of $1.58. This resulted in the Chief Commercial Officer holding 69,303 shares of ESPR after the transaction. In another insider transaction, Warren Eric sold 603 shares at $1.48 per share on Jun 21. Company shares held by the Chief Commercial Officer now total 69,409.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ESPR in the last 3 months, the mean price target is $8.54 with high estimates of $22.00 and low estimates of $2.80. In terms of 52-week highs and lows, ESPR has a high of $7.24 and a low of $0.70.
As of this writing, ESPR has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.34 per share and a lower estimate of -$0.62. The company reported an EPS of -$0.46 in the last quarter, which was 24.60% higher than expectations of -$0.61.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ESPR’s latest balance sheet shows that the firm has $259.33M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was -$3.66, while its Total Shareholder’s Equity was -$196.94M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 4.13.
